Achieving Good Glycemic Control Early After Onset of Diabetes: A Cost-Effectiveness Analysis in Patients with Type 1 Diabetes in Sweden

Good Glycemic Control ◽

Effectiveness Analysis ◽

Onset Of Diabetes

Cost-effectiveness analysis of an Advanced Hybrid Closed Loop insulin delivery system in people with type 1 diabetes in Greece

Diabetes Technology & Therapeutics ◽

10.1089/dia.2021.0443 ◽

2021 ◽

Author(s):

Vaia Lambadiari ◽

Asli Zeynep Ozdemir Saltik ◽

Simona de Portu ◽

Maria Ida Buompensiere ◽

Aikaterini Kountouri ◽

...

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

Delivery System ◽

Closed Loop ◽

Insulin Delivery ◽

Effectiveness Analysis ◽

Insulin Delivery System

Cost-Effectiveness Analysis of a Hybrid Closed-Loop System Versus Multiple Daily Injections and Capillary Glucose Testing for Adults with Type 1 Diabetes

Diabetes Technology & Therapeutics ◽

10.1089/dia.2020.0064 ◽

2020 ◽

Vol 22 (11) ◽

pp. 812-821 ◽

Cited By ~ 2

Author(s):

Anthony Pease ◽

Ella Zomer ◽

Danny Liew ◽

Arul Earnest ◽

Georgia Soldatos ◽

...

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

Closed Loop ◽

Closed Loop System ◽

Glucose Testing ◽

Effectiveness Analysis ◽

System Versus ◽

Capillary Glucose

A Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension versus Standard Pump Therapy for Hypoglycemic Unaware Patients with Type 1 Diabetes

Value in Health ◽

10.1016/j.jval.2014.05.008 ◽

2014 ◽

Vol 17 (5) ◽

pp. 561-569 ◽

Cited By ~ 27

Author(s):

Trang T. Ly ◽

Alan J.M. Brnabic ◽

Andrew Eggleston ◽

Athena Kolivos ◽

Margaret E. McBride ◽

...

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

Insulin Pump ◽

Insulin Pump Therapy ◽

Pump Therapy ◽

Insulin Suspension ◽

A Cost-Effectiveness Analysis of Continuous Subcutaneous Insulin Injection versus Multiple Daily Injections in Type 1 Diabetes Patients: A Third-Party US Payer Perspective

Value in Health ◽

10.1111/j.1524-4733.2008.00478.x ◽

2009 ◽

Vol 12 (5) ◽

pp. 674-686 ◽

Cited By ~ 27

Author(s):

Meaghan St Charles ◽

Peter Lynch ◽

Claudia Graham ◽

Michael E. Minshall

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

Insulin Injection ◽

Third Party ◽

Subcutaneous Insulin ◽

Multiple Daily Injections ◽

Effectiveness Analysis ◽

Payer Perspective

Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden

Diabetes Therapy ◽

10.1007/s13300-017-0294-z ◽

2017 ◽

Vol 8 (5) ◽

pp. 1015-1030 ◽

Cited By ~ 8

Author(s):

Johan Jendle ◽

Jayne Smith-Palmer ◽

Alexis Delbaere ◽

Simona de Portu ◽

Natalie Papo ◽

...

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

Insulin Pump ◽

Insulin Pump Therapy ◽

Pump Therapy ◽

Insulin Suspension ◽

A Cost Effectiveness Analysis of Group Care in Type 2 and Type 1 Diabetes

Frontiers in Diabetes - Embedding Education into Diabetes Practice ◽

10.1159/000088088 ◽

2005 ◽

pp. 117-131 ◽

Cited By ~ 1

Author(s):

Piervincenzo Bondonio ◽

Marina Trento ◽

Massimo Porta

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

Group Care ◽

Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain

Endocrinología Diabetes y Nutrición (English ed ) ◽

10.1016/j.endien.2018.08.001 ◽

2018 ◽

Vol 65 (7) ◽

pp. 380-386

Author(s):

Ignacio Conget ◽

Pilar Martín-Vaquero ◽

Stéphane Roze ◽

Isabel Elías ◽

Cristina Pineda ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Cost Effectiveness ◽

High Risk ◽

Type 1 Diabetes Mellitus ◽

Pump Therapy ◽

Effectiveness Analysis ◽

Low Glucose

Bringing Stem Cell‐Based Therapies for Type 1 Diabetes to the Clinic: Early Insights from Bioprocess Economics and Cost‐Effectiveness Analysis

Biotechnology Journal ◽

10.1002/biot.201800563 ◽

2019 ◽

Vol 14 (8) ◽

pp. 1800563 ◽

Cited By ~ 3

Author(s):

Cátia Bandeiras ◽

Joaquim M. S. Cabral ◽

Robert A. Gabbay ◽

Stan N. Finkelstein ◽

Frederico Castelo Ferreira

Keyword(s):

Type 1 Diabetes ◽

Stem Cell ◽

Cost Effectiveness ◽

Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis

Diabetes Therapy ◽

10.1007/s13300-020-00980-1 ◽

2020 ◽

Cited By ~ 1

Author(s):

Johan Jendle ◽

Åsa Ericsson ◽

Jens Gundgaard ◽

Jonas Bech Møller ◽

William J. Valentine ◽

...

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

Clinical Outcomes ◽

Lower Cost ◽

Standard Of Care ◽

Effectiveness Analysis ◽

Standard Of Care Treatment ◽

Insulin Pens

CARDIOVASCULAR SCREENING IN ASYMPTOMATIC TYPE 1 DIABETES PATIENTS: PRELIMINARY RESULTS AND MODEL PROPOSAL FOR A COST-EFFECTIVENESS ANALYSIS

Journal of Hypertension ◽

10.1097/01.hjh.0000746228.89567.25 ◽

2021 ◽

Vol 39 (Supplement 1) ◽

pp. e165

Author(s):

Simon Helleputte ◽

Bruno Lapauw ◽

Patrick Calders ◽

Tine De Backer

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

Preliminary Results ◽

Cardiovascular Screening ◽

Effectiveness Analysis ◽

Diabetes Patients